Johnson & Johnson
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson North America employees by Year
Johnson & Johnson North America employees: 49,462 in FY2025, up 5.8% from a year earlier.
Latest, FY2025
49,462
Period ended Dec 28, 2025
Change on a year earlier
+5.8%
46,770 in FY2024
History
3 years
Since FY2023
Sources
1
J&J 2025 Health for Humanity Report
Where the FY2025 figure comes from
“North America 49,462 46,770 48,061”
Source: J&J 2025 Health for Humanity Report ↗
Reported in 2025 Health for Humanity Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | North America employees | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 49,462 | +5.8% | J&J 2025 Health for Humanity Report ↗ |
| FY2024 | Dec 29, 2024 | 46,770 | -2.7% | J&J 2025 Health for Humanity Report ↗ |
| FY2023 | Dec 31, 2023 | 48,061 | – | J&J 2025 Health for Humanity Report ↗ |
Cite this data
StockData. (2026). Johnson & Johnson North America employees, annual FY2023–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/esg-emp-na
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.